Package 70518-0625-1

Brand: topiramate

Generic: topiramate
NDC Package

Package Facts

Identity

Package NDC 70518-0625-1
Digits Only 7051806251
Product NDC 70518-0625
Description

30 POUCH in 1 BOX, UNIT-DOSE (70518-0625-1) / 1 TABLET in 1 POUCH (70518-0625-2)

Marketing

Marketing Status
Marketed Since 2019-10-22
Brand topiramate
Generic topiramate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "47fa78bf-bc44-7178-e063-6394a90a8719", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["199888"], "spl_set_id": ["0cf388dc-d8f1-4478-bf5f-e64638ee5801"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 POUCH in 1 BOX, UNIT-DOSE (70518-0625-1)  / 1 TABLET in 1 POUCH (70518-0625-2)", "package_ndc": "70518-0625-1", "marketing_start_date": "20191022"}], "brand_name": "Topiramate", "product_id": "70518-0625_47fa78bf-bc44-7178-e063-6394a90a8719", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70518-0625", "generic_name": "Topiramate", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA076343", "marketing_category": "ANDA", "marketing_start_date": "20170717", "listing_expiration_date": "20271231"}